Paid-in Capital Increase Decision Amendment
애드바이오텍
179530
Signal Score
Historical Avg Return (5d)
+0.72%
Data Coverage
100%n=2249
Risk-adjusted indicator based on 2249 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • Event Type: Paid-in Capital Increase
AI Analysis Summary
ADBIOTECH Co.,Ltd. has announced an amendment to its decision regarding a paid-in capital increase. While specific figures are not available, a capital increase typically leads to share dilution, potentially negatively impacting existing shareholder value. The purpose of the funds and the issuance price would be critical for a more detailed assessment.
Risk Factors
Pro plan
Access Full Korean Market Signal Analytics
✔ AI-parsed DART filing classification & scoring
✔ Real-time event impact indicators
✔ Price reaction & historical pattern data
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.